Key Highlights
- Net sales were $22.7 billion, up 1% from the prior year.
- IFRS Adjusted EBITDA was $1,181 million, down 36% from the prior year.
- USGAAP Adjusted EBITDA was $1,001 million, down 38%.
- Free Cash Flow was negative US$167 million in the third quarter of 2026.
JBS (NYSE:JBS) reported third-quarter 2026 net sales of $22.7 billion, an increase of 1% from the prior year. On an IFRS basis, adjusted EBITDA was $1,181 million, down 36%, while on a USGAAP basis adjusted EBITDA was $1,001 million, down 38%. Free cash flow for the quarter was negative US$167 million, the company reported.
Net Sales and Margins
Net sales reached $22.7 billion, up 1% from the third quarter of 2025. The company reported monthly Margin figures for the quarter. Monthly margins moved from negative 2.9% in July to breakeven in August and to a positive margin in September, according to the company's report.
The company's results include the effect of production trends during the quarter. Production in one area peaked with 4.7% growth in July and subsequently slowed throughout the quarter, the company reported.
Adjusted EBITDA and Operating Income
IFRS adjusted Operating Income was $521 million, down 58% from the prior year. USGAAP adjusted operating income was $597 million, down 53%. Each of these measures is a non-GAAP figure, with the reconciliations provided in later sections of the company's report.
The company's free cash flow decline was $551 million year over year. The company attributed the change to a $653 million decline in adjusted EBITDA and to higher Working Capital consumption during the period.
Free Cash Flow and Balance Sheet
Free cash flow was negative US$167 million for the third quarter of 2026. The figure followed a free cash flow result in the prior-year period that was $551 million higher, according to the company's comparison.
These figures are calculated under the company's reporting framework.
Final Word
JBS reported third-quarter 2026 net sales of $22.7 billion, up 1%, IFRS adjusted EBITDA of $1,181 million, down 36%, USGAAP adjusted EBITDA of $1,001 million, down 38%, and negative free cash flow of US$167 million, a decrease of $551 million year over year.

_11_12_2026_08_31_17_260646.jpg)




Please wait processing your request...